Cargando…
Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic
For patients with cardiac implantable electronic devices (CIEDs), arrythmias such as atrial fibrillation (AF) can be detected and actions taken to rapidly assess and initiate treatment where appropriate. Actions include timely initiation of anticoagulation, review of blood pressure, and optimization...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037589/ https://www.ncbi.nlm.nih.gov/pubmed/36961026 http://dx.doi.org/10.3390/pharmacy11020048 |
_version_ | 1784911913642098688 |
---|---|
author | Schellhase, Ellen Stanko, Madeline Kinstler, Natalie Miller, Monica L. Antoniou, Sotiris Fhadil, Sadeer Patel, Mital Wright, Paul |
author_facet | Schellhase, Ellen Stanko, Madeline Kinstler, Natalie Miller, Monica L. Antoniou, Sotiris Fhadil, Sadeer Patel, Mital Wright, Paul |
author_sort | Schellhase, Ellen |
collection | PubMed |
description | For patients with cardiac implantable electronic devices (CIEDs), arrythmias such as atrial fibrillation (AF) can be detected and actions taken to rapidly assess and initiate treatment where appropriate. Actions include timely initiation of anticoagulation, review of blood pressure, and optimization of cholesterol/lipids to prevent unfavorable outcomes, such as stroke and other cardiovascular complications. Delays to initiating anticoagulation can have devastating consequences. We sought to implement a virtual clinic, where a pharmacist reviews patient referrals from a CIED clinic after detecting AF from the CIED. Anticoagulation choice is determined by patient-specific factors, and a shared patient–provider decision to start oral anticoagulation is made. In addition, blood pressure readings and medications are assessed with lipid-lowering therapies for optimization. A total of 315 patients have been admitted through this clinic and anticoagulated over a two-year span; in addition, 322 successful interventions were made for optimization of cardiac therapy. Rapid initiation of anticoagulation within five days of referral was likely to have reduced unfavorable outcomes, such as stroke and other cardiovascular optimizations, leading to improved patient outcomes. |
format | Online Article Text |
id | pubmed-10037589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100375892023-03-25 Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic Schellhase, Ellen Stanko, Madeline Kinstler, Natalie Miller, Monica L. Antoniou, Sotiris Fhadil, Sadeer Patel, Mital Wright, Paul Pharmacy (Basel) Communication For patients with cardiac implantable electronic devices (CIEDs), arrythmias such as atrial fibrillation (AF) can be detected and actions taken to rapidly assess and initiate treatment where appropriate. Actions include timely initiation of anticoagulation, review of blood pressure, and optimization of cholesterol/lipids to prevent unfavorable outcomes, such as stroke and other cardiovascular complications. Delays to initiating anticoagulation can have devastating consequences. We sought to implement a virtual clinic, where a pharmacist reviews patient referrals from a CIED clinic after detecting AF from the CIED. Anticoagulation choice is determined by patient-specific factors, and a shared patient–provider decision to start oral anticoagulation is made. In addition, blood pressure readings and medications are assessed with lipid-lowering therapies for optimization. A total of 315 patients have been admitted through this clinic and anticoagulated over a two-year span; in addition, 322 successful interventions were made for optimization of cardiac therapy. Rapid initiation of anticoagulation within five days of referral was likely to have reduced unfavorable outcomes, such as stroke and other cardiovascular optimizations, leading to improved patient outcomes. MDPI 2023-03-03 /pmc/articles/PMC10037589/ /pubmed/36961026 http://dx.doi.org/10.3390/pharmacy11020048 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Schellhase, Ellen Stanko, Madeline Kinstler, Natalie Miller, Monica L. Antoniou, Sotiris Fhadil, Sadeer Patel, Mital Wright, Paul Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic |
title | Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic |
title_full | Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic |
title_fullStr | Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic |
title_full_unstemmed | Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic |
title_short | Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic |
title_sort | analysis of pharmacy cardiac optimization clinic for patients with new onset atrial fibrillation detected via cardiac implantable electronic device clinic |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037589/ https://www.ncbi.nlm.nih.gov/pubmed/36961026 http://dx.doi.org/10.3390/pharmacy11020048 |
work_keys_str_mv | AT schellhaseellen analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic AT stankomadeline analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic AT kinstlernatalie analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic AT millermonical analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic AT antoniousotiris analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic AT fhadilsadeer analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic AT patelmital analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic AT wrightpaul analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic |